TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients

NCT01202825 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: TMC647055
DRUG: Placebo
DRUG: TMC647055
DRUG: TMC647055
DRUG: Placebo
DRUG: TMC435
DRUG: Placebo
DRUG: TMC647055
DRUG: Placebo
DRUG: TMC647055

Sponsor

Tibotec Pharmaceuticals, Ireland